Publication | Closed Access
Intravenous Lidocaine in the Treatment of Convulsions in the Neonatal Period
39
Citations
0
References
1990
Year
NeonatologyIntravenous LidocaineThirteen Newborn InfantsPharmacotherapyPharmacokineticsLd ClearanceAnesthetic PharmacologyLd ConcentrationAnesthesia PracticeNeuropharmacologyNewborn MedicinePharmacologyAnaesthetic AgentNeurophysiologyPediatricsClinical PharmacologyAnesthesiaMedicineNeonatal PeriodAnesthesiology
Thirteen newborn infants (five premature, eight full term) with severe seizures and not responding to phenobarbital and diazepam received a lidocaine (LD) infusion. The schedule was 4 mg/kg/h on the 1st day, 3 mg/kg/h on the 2nd day, 2 mg/kg/h on the 3rd day, and 1 mg/kg/h on the 4th day. The LD plasma levels were measured every 24 h just before decreasing the dose. The control of seizures was achieved in 11 of 13 patients, with plasma LD concentration ranging from 2.8 to 10.5 mg/L. The LD concentration was linearly correlated with the dose in each group. In the premature group, LD clearance was always smaller than in the full-term group. Although no side effects were observed on heart rate and blood pressure, it is suggested that the dose of LD be adjusted to maintain the LD concentrations between 3-6 mg/L.